Open original FDA record ↗Recall record
- FDA identifier
- Z-1048-2023
- Company in FDA record
- W L Gore & Associates, Inc.
- FDA classification date
- Feb 1, 2023
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Septal Occluders released with incomplete quality test documentation that assesses the release of the device from the delivery system during the index procedure. A potential failure of this quality test could potentially result could result in occluder embolization, anoxic brain injury, central venous or arterial perforation or rupture.
Source facts
- Action
- On 12/14/22, recall notices were mailed to customers informing them to take the following actions: 1) Identify and return any unused devices. 2) Complete and return the customer response form to to FieldActionTeam@wlgore.com 3) This notice needs to be shared with those who should be aware within your institution or to any organization where potentially affected devices have been transferred. Customers with questions can contact the firm at MPDCustomerCare@wlgore.com
- Initiated
- 2022-12-14
- Root cause
- Employee error
- Distribution
- US Nationwide distribution in the states of NY, CA, FL, CT, TX, AR, IN, MA, MO, SD, VA.
- Recall number
- Z-1048-2023
- Recall status
- Open, Classified
- CDRH record ID
- 197593
- FDA classified
- 2023-02-01
- Recall event number
- 91380